Cellyan Biotechnology receives Nasdaq bid price deficiency notice Jan 16, 2026 04:31PM
Cellyan Biotechnology receives Nasdaq bid price deficiency notice Jan 16, 2026 04:31PM
DCS Announces Q3 2025 Quarterly Financial Statements Dec 1, 2025 08:30AM